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The World Health Organization’s “Coordinated Global Research Roadmap: 2019 Novel
Coronavirus” outlined the need for research that focuses on the impact of COVID-19 on
pregnant women and children. More than one year after the first reported case significant
knowledge gaps remain, highlighting the need for a coordinated approach. To address this
need, the Maternal, Newborn and Child Health Working Group (MNCH WG) of the COVID-
19 Clinical Research Coalition conducted an international survey to identify global research
priorities for COVID-19 in maternal, reproductive and child health.
Method
This project was undertaken using a modified Delphi method. An electronic questionnaire
was disseminated to clinicians and researchers in three different languages (English,
French and Spanish) via MNCH WG affiliated networks. Respondents were asked to select
the five most urgent research priorities among a list of 17 identified by the MNCH WG. Anal-
ysis of questionnaire data was undertaken to identify key similarities and differences among
respondents according to questionnaire language, location and specialty. Following
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elimination of the seven lowest ranking priorities, the questionnaire was recirculated to the
original pool of respondents. Thematic analysis of final questionnaire data was undertaken
by the MNCH WG from which four priority research themes emerged.
Results
Questionnaire 1 was completed by 225 respondents from 29 countries. Questionnaire 2
was returned by 49 respondents. The four priority research themes which emerged from the
analysis were 1) access to healthcare during the COVID-19 pandemic, 2) the direct and 3)
indirect effects of COVID-19 on pregnant and breastfeeding women and children and 4) the
transmission of COVID-19 and protection from infection.
Conclusion
The results of these questionnaires indicated a high level of concordance among continents
and specialties regarding priority research themes. This prioritized list of research uncertain-
ties, developed to specifically highlight the most urgent clinical needs as perceived by
healthcare professionals and researchers, could help funding organizations and research-
ers to answer the most pressing questions for clinicians and public health professionals dur-
ing the pandemic. It is hoped that these identified priority research themes can help focus
the discussion regarding the allocation of limited resources to enhance COVID-19 research
in MNCH globally.
Introduction
More than one year has passed since the first case of COVID-19 was reported on 31st Decem-
ber 2019 [1], leading to the declaration of a pandemic by the World Health Organization
(WHO) on 11th March 2020. Since its emergence, there has been a surge of research conducted
to understand how COVID-19 affects pregnant women, their developing fetuses and children.
The WHO report entitled “A Coordinated Global Research Roadmap: 2019 Novel Coronavirus”
outlined the need for research that focuses on the impact of COVID-19 on pregnant women
and children, however, there are still considerable gaps in this knowledge [2]. Much of the data
relating to COVID-19 has been derived from research conducted in high-income countries
(HICs), producing findings that may not be relevant or generalizable to women and children
in low-and middle-income countries (LMICs). Furthermore, health systems and public health
strategies used to control the spread of the virus in different parts of the world may vary
according to the availability of funding and resources, meaning a “one-size-fits-all” approach
cannot be appropriately applied to determine research priorities in different global regions [3,
4]. The emergence of geographically distributed genomic variants of the SARS-CoV-2 virus
has also highlighted the importance of understanding the demographic contexts in which
these variants spread and has raised important questions about the impact of diet and the gut
microbiome on host immunity to the virus [5]. Such knowledge would be of particular impor-
tance to pregnant and breastfeeding women and children in resource-limited regions where
surveillance of variants of concern is low and poor nutrition is common. [6].
Considering these varying needs, it is imperative that we strive to understand research pri-
orities in different international regions. Such an approach is necessary to target funding,
resources and research efforts where needed, and to guide policy makers to ensure that efforts
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are made to address the most pressing research questions for pregnant women and children.
To address these needs, the Maternal, Newborn and Child Health Working Group (MNCH
WG) of the COVID-19 Clinical Research Coalition, which is comprised of obstetricians, gyne-
cologists, public health physicians and pediatricians, conducted an international survey to
identify the most pressing COVID-19 research priorities in maternal, reproductive and child
health [7]. In pursuing this line of work, we sought to identify priorities that were equitable,
internationally representative, and also representative of the diverse specialties caring for preg-
nant women and children globally. We also sought to complement other COVID-19 research
priority setting exercises currently being undertaken in this field [8, 9], in order to provide a
broader insight into the needs of women and children around the world.
Methods
Development and dissemination of questionnaires
This project was undertaken between October 2020 and January 2021 using a modified Delphi
method (Fig 1). A short online questionnaire was designed by the MNCH WG through collab-
orative discussions guided by the WHO’s “Coordinated Global Research Roadmap for the
Novel Coronavirus” [2]. Questionnaire respondents were asked to provide demographic infor-
mation including specialty and location, and to select the five most urgent research priorities
among a list of 17 which had been generated by the MNCH WG through literature review and
expert opinion (S1 File). Space was also provided within the questionnaire for respondents to
include additional research priorities that were not included in the list. The questionnaire was
translated from English into French and Spanish and disseminated electronically using the
SurveyMonkey platform via affiliated networks of the MNCH WG members including: World
Society for Pediatric Infectious Diseases (WSPID); European Society for Pediatric Infectious
Diseases (ESPID); African Society for Pediatric Infectious Diseases (AfSPID), who forwarded
to their respective in-country pediatric and obstetric associations; Honduran Pediatric Associ-
ation; Royal College of Obstetricians and Gynaecologists (RCOG) and Royal College of Paedi-
atrics and Child Health (RCPCH), who forwarded to their global health membership;
American College of Obstetricians and Gynecologists (ACOG) and International Federation
of Gynecology and Obstetrics (FIGO), who also forwarded to all its country member organiza-
tions for further dissemination [10–16]. We also disseminated the Questionnaire 1 via the
social media platforms Twitter and Facebook [17, 18]. Responses were collected electronically
over a period of four weeks and data analysis was performed using Microsoft Excel.
Data collection and analysis
The frequency of selection of each research priority was calculated (with each research priority
being equally weighted). Subgroup analysis of Questionnaire 1 data was performed to deter-
mine the frequency of selection of each research priority according to questionnaire language,
respondent specialty and respondent location (continent). An overview of additional research
priorities submitted by respondents was also undertaken by the MNCH WG to determine
whether they were sufficiently distinct from the original listed priorities (no new priorities
were added). Following this review, the seven least frequently selected research priorities by
questionnaire respondents among the original list of 17 (as indicated by the seven lowest
scores) were eliminated from the list, leaving ten research priorities which were reviewed and
refined by the MNCH WG and recirculated to respondents to Questionnaire 1 who had con-
sented to being recontacted (S2 File). Respondents were asked to rank these ten research prior-
ities from most to least important (with 1 signifying the most important priority and 10
signifying the least important priority) and to comment on the relevance and
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Fig 1. Overview of the modified Delphi method implemented for the development of the maternal, reproductive
and child health COVID-19 priority research themes, October 2020–January 2021.
https://doi.org/10.1371/journal.pone.0257516.g001
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comprehensibility of the research priorities. Responses to Questionnaire 2 were also collected
over a period of four weeks. The mean ranking of each research priority was calculated by
dividing the sum of the rankings for each research priority by the total number of respondents
to Questionnaire 2. We subsequently performed a thematic analysis of the most frequently
selected priorities from Questionnaire 1 and the highest ranked priorities among the responses
to Questionnaire 2, through which four principal research priority themes emerged. The
MNCH WG reconvened to define important research questions within each theme. Three key
questions within each research priority theme were developed following literature review to
identify persisting knowledge gaps. We then presented the research questions to OBGYN and
pediatric specialists at virtual international meetings to ensure agreement among specialists
within the field.
Ethical consideration
This project was reviewed by the Public Health England Research Ethics and Governance
Group. Given the consultative nature of the surveys, the project was deemed not to require full




Questionnaire 1 was completed by 225 respondents from 29 countries across five continents
(Fig 2). The full list of countries can be found in S3 File. The demographic characteristics of
Questionnaire 1 respondents and most frequently selected research priorities according to
questionnaire language, respondent specialty and location are shown in Table 1.
Questionnaire 2 was disseminated to 173 members of our original pool of experts (52
declined to be recontacted) and was returned by 49 respondents. The research priority from
Questionnaire 2 with the highest mean ranking was “Access to healthcare for children during
the COVID-19 pandemic” which had an average score of 3.86/10. The lowest ranked priority
was “Mental health sequelae of COVID-19 pandemic in pregnancy and postnatal periods”
which had a mean ranking of 6.59/10. The mean ranking of each of the top 10 research priori-
ties is shown in Fig 3.
The four priority research themes identified were 1) access to healthcare during the
COVID-19 pandemic, 2) the direct and 3) indirect effects of COVID-19 on pregnant and
breastfeeding women and children and 4) the transmission of COVID-19 and protection from
infection.
Priority research themes
1) Access to healthcare, treatment and vaccine trials for women and children during the
COVID-19 pandemic. Evaluating access to maternal and sexual health services for women
in vulnerable groups was the most frequently selected research priority among questionnaire
respondents based in Africa and was the second most frequently selected research priority
among respondents from all other regions (Box 1). Access to medication and vaccines was also
highlighted as “the inclusion of pregnant and breastfeeding women in COVID-19 vaccine tri-
als” was the most frequently selected priority by North American respondents and the fifth
most frequently selected research priority among infectious disease specialists who responded
to Questionnaire 1 (Box 1).
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2) Direct effects of COVID-19 on pregnant and breastfeeding women and children.
The direct effects of COVID-19 on pregnant women, fetuses and children was the most fre-
quently selected research priority among OB/GYN and infectious diseases respondents and
also among respondents from Central and South America (Box 2).
Understanding the neurodevelopmental effects of exposure to the SARS-CoV-2 virus on
fetuses and infants was deemed to be the highest priority among our pediatric specialist
respondents and was the second highest priority among Central and South American respon-
dents. Determining the mechanism of the severe form of COVID-19 in children, pediatric
multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS),
also known as multisystem inflammatory syndrome in children (MIS-C), was also among the
five most frequently selected priorities by pediatric specialist respondents to Questionnaire 1
(Box 2).
3) Indirect effects of COVID-19 on pregnant and breastfeeding women and children.
Understanding the indirect effects of the COVID-19 pandemic was the most frequently
selected research priority among Questionnaire 1 respondents from Europe and among the
three most frequently selected research priorities among OB/GYN, sexual and reproductive
health, and public health specialists (Box 3).
4) Transmission of COVID-19 and protection from infection. Transmission modes
and risk and infection prevention and control measures for pregnant women and infants born
to mothers infected with the virus during pregnancy and in the postpartum period was among
the four most frequently selected research priorities for Asian, African and North American
respondents (Box 4).
Fig 2. Geographical heat map showing the location of Questionnaire 1 respondents. Grey = no respondents based in this country. Light green = 1 respondent. Dark
blue = 90 respondents. (The number of respondents corresponds to the shade of green or blue as shown within the spectrum of the color key).
https://doi.org/10.1371/journal.pone.0257516.g002
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Discussion
Context of study findings
The advent of the COVID-19 pandemic has seen unprecedented amounts of pressure being
placed on healthcare systems around the world. Acute and critical care services in many coun-
tries have been overstretched, leading to the redeployment of many healthcare professionals to
the front line and causing a reduction in the provision of “non-urgent” services. In light of
this, we must examine what effect these changes have had on women’s and children’s ability to
access maternal, sexual and reproductive and child healthcare services during this time. This is
particularly pertinent for vulnerable members of society including adolescent girls and unmar-
ried women among migrant and refugee populations who were already facing challenges in
accessing these services prior to the onset of the pandemic [19, 20].
Table 1. Demographic characteristics of Questionnaire 1 respondents and the most frequently selected research priorities according to questionnaire language,
respondent specialty and location.
Characteristic Number of respondents n = 225
(%)
Most frequently selected research priority
Questionnaire language
English+ 99 (44.0) Access to maternal, sexual, and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Direct impact of COVID-19 on pregnant and infant populations
French 17 (7.6) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Spanish 109 (48.4) Direct impact of COVID-19 on pregnant and infant populations
Respondent specialty�
Obstetrics and Gynecology 86 (38.2) Direct impact of COVID-19 on pregnant and infant populations
Pediatrics 82 (36.4) Neurodevelopment of infants and young children exposed to COVID-19
Sexual and Reproductive
Health
14 (6.2) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Midwifery and Nursing 9 (4.0) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Infectious Diseases 10 (4.4) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Access to healthcare for children during the COVID-19 pandemic
Direct impact of COVID-19 on pregnant and infant populations
Infection prevention and control
Public Health 31 (13.8) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Epidemiology 11 (4.9) Neurodevelopment of infants and young children exposed to COVID-19
Other 17 (7.6) Indirect effects of the COVID-19 pandemic on pregnant and infant populations
Respondent location
Africa 25 (11.1) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
Asia 49 (21.8) Direct impact of COVID-19 on pregnant and infant populations
Europe 16 (7.1) Indirect effects of the COVID-19 pandemic on pregnant and infant populations
Central and South America 115 (51.1) Direct impact of COVID-19 on pregnant and infant populations
North America 10 (4.4) Inclusion of pregnant and breastfeeding women in COVID-19 vaccine trials
Unknown 10 (4.4) Access to maternal, sexual and reproductive healthcare among vulnerable groups during the
COVID-19 pandemic
�Questionnaire respondents were permitted to select more than one specialty therefore the percentage total is >100%.
+More than one research priority was most frequently selected among respondents in this category.
https://doi.org/10.1371/journal.pone.0257516.t001
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Throughout 2020, pregnant and breastfeeding women were systematically excluded from
most COVID-19 treatment and vaccine trials despite urgent calls for their inclusion [21]. Con-
cerns around the lack of safety data also meant that pregnant and breastfeeding women were
not prioritized to receive the vaccines after their approval, despite evidence that pregnant
women were of greater risk of disease complications [22, 23]. In April 2021, the United States
Centers for Disease Control and Prevention (US CDC) announced that pregnant and
Fig 3. Average rankings of the MNCH research priorities included in Questionnaire 2.
https://doi.org/10.1371/journal.pone.0257516.g003
Box 1. Access to healthcare, treatment and vaccine trials for women and
children during the COVID-19 pandemic
Priority research questions
1. How has the COVID-19 pandemic response affected the availability of and access
to maternal, sexual, and reproductive health services?
2. What effect has the COVID-19 pandemic response had on the availability of and
ability to access child and adolescent health services?
3. What ethical and practical considerations would allow pregnant and breastfeeding
women and children equitable access to future COVID-19 treatment and vaccine
clinical trials?
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breastfeeding women could safely receive these vaccines after real world data from more than
90,000 pregnant women did not identify any safety concerns, however, this came five months
after these vaccine were authorized for use in non-pregnant adults [24–27]. While some inter-
ventional studies, such as the RECOVERY trial [28], had widened recruitment to include preg-
nant and breastfeeding women and children by late 2020, the first large-scale COVID-19
vaccine trial which included pregnant women only commenced recruitment in early 2021
[29]. A framework for the ethical and practical considerations of the inclusion of pregnant and
breastfeeding women and children in COVID-19 treatment and vaccine trials is urgently
needed to ensure that these groups are appropriately considered for inclusion within future
treatment and vaccine trials, both in the current pandemic and in future public health emer-
gencies [30].
Data from the US CDC has shown that pregnant women are at greater risk of intensive care
unit admission and death due to COVID-19 than non-pregnant women, and early research
suggests that poorer birth outcomes will likely be more prevalent among pregnant women
Box 2. Direct effects of COVID-19 on pregnant and breastfeeding women
and children
Priority research questions
1. Why are pregnant women with COVID-19 at increased risk of hospitalization,
intensive care unit admission and death compared to non-pregnant women? Is
there an immunopathological basis for these outcomes?
2. What are the neurodevelopmental effects of exposure to the SARS-CoV-2 virus in
utero?
3. What is the immunopathological mechanism of severe COVID-19 in children–
pediatric multisystem inflammatory syndrome temporally associated with SARS-
CoV-2 (PIMS-TS)?
Box 3. Indirect effects of the COVID-19 pandemic on pregnant and breast-
feeding women and children
Priority research questions
1. What is the effect of the pandemic on rates of sexual and gender-based violence
and maternal and child mental health?
2. How will the disruption of routine childhood disease prevention services affect
future rates of vaccine preventable diseases?
3. What are the long-term effects of the disruptions in education on childhood
development?
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from vulnerable populations within LMICs [22, 23, 31–33]. Additional observational studies
have also identified that women diagnosed with COVID-19 during pregnancy are at higher
risk for pre-eclampsia, preterm delivery and stillbirth than women who did not have COVID-
19 during their pregnancy [22, 31, 34, 35]. The increased severity of illness among pregnant
women observed in the US and UK during the second wave of the pandemic has also raised
questions about whether emerging variants of the SARS-CoV-2 virus may be more pathogenic
in pregnancy [36]. Greater emphasis should be placed on establishing the pathophysiological
and immunological bases for these outcomes and understanding the mechanisms through
which these complications occur. Universal screening of pregnant women for COVID-19 may
also facilitate greater inclusion of asymptomatic carriers in future studies, which may further
improve our understanding of the full breadth of effects of COVID-19 in pregnancy and
beyond, as well as providing data about the genomic divergence among the viral strains caus-
ing infection in this cohort of women. Where logistically and financially feasible, efforts should
be made to upscale COVID-19 testing to facilitate the identification of women who may be at
greater risk of complications [37, 38].
The impact of COVID-19 on developing fetuses and the manifestation of severe disease in
children remain poorly elucidated. While observational data from HICs have led to an under-
standing of potential risk factors for this disorder, including older age and non-white ethnicity
(observed in both the UK and South Africa), the immunopathological basis for manifestations
of severe disease remains unascertained [39, 40]. A large proportion of children diagnosed
with PIMS-TS require critical care admission and suffer significant morbidity, including the
development of coronary artery aneurysms, shock and multi-organ failure [39, 41]. Strength-
ening our understanding of the causes of this manifestation will help advance therapeutic and
management protocols which may help to slow progression of disease [40].
While COVID-19 has been seen to directly impact the health of pregnant women and their
infants, it is also important that we understand the effect that the behavioral and societal
responses to the pandemic have had on this cohort. A notable rise in sexual and gender based
violence has been documented in many global regions during the pandemic, and while
research has identified higher rates of self-reported depression and anxiety among pregnant
and postpartum women, a reduction in mental health and support services has also been
noted in many parts of the world [42–45]. In light of this, we must also seek to better under-
stand the full extent of the challenges these women face in order to design more robust support
measures for them as the pandemic persists.
Box 4. Transmission of COVID-19 and protection from infection
Priority research questions
1. Is there evidence of mother-to-child transmission of COVID-19? If so, what are
the potential routes of transmission?
2. Do maternally-derived antibodies against the SARS-CoV-2 virus confer protective
immunity against COVID-19 in infants?
3. What is the evidence for current infection prevention control measures recom-
mended for pregnant and breastfeeding women?
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Disruptions in the provisions and access to healthcare services for children, particularly
during infancy, may also have unintended consequences on the prevalence of other communi-
cable diseases. Some LMICs have seen disruptions in their ability to provide vaccinations in
accordance with their national immunization schedules, owing to both limitations in health-
care resources and the inability of parents and caregivers to bring their children to healthcare
facilities due to increased poverty and travel restrictions [46]. This disruption may result in
outbreaks of vaccine-preventable diseases in future years, thus, it is important to develop the
infrastructures necessary to strengthen immunization programs, facilitate the provision of
catch-up vaccinations and where possible, and to monitor disease outbreaks to minimize the
re-emergence of such diseases within these communities [47].
Lockdown measures implemented in many countries have also led to long-term closures of
schools and other educational institutions across the world, with remote learning via online
platforms replacing face-to-face learning in many countries. The introduction of remote learn-
ing has unfortunately served to further disadvantage millions of children from marginalized
communities [48]. Long-term longitudinal studies may be necessary to understand how this
disruption in schooling has affected child development and objective educational levels in chil-
dren, particularly among children in resource-limited regions of the world who have faced
prolonged restricted access to learning resources during the pandemic.
Understanding the risk and routes of transmission of any communicable disease is essential
for controlling its spread. Identifying the potential routes of mother-to-child-transmission of
COVID-19 is of particular importance for healthcare professionals to be able to provide appro-
priate care and advice for pregnant and breastfeeding women to minimize the risks posed to
their infant. Additionally, understanding the impact of maternal COVID-19 infection on the
development of the neonatal microbiome will also be important in providing appropriate
nutritional support for these children during infancy [49]. It is well known that some viral
infections during pregnancy can have devastating effects on the developing fetus, yet there
have been few large-scale studies which involve the collection of samples from pregnant
women infected with COVID-19 to determine the routes through which the virus, and immu-
nity to the virus, can be passed from mother to child. There is emerging evidence that suggests
that maternally-derived IgG antibodies against the SARS-CoV-2 virus can be transferred to
the developing fetus transplacentally [50]. There is also evidence that IgA antibodies against
the SARS-CoV-2 virus can also found in the breastmilk, although it is not yet determined
whether this is sufficient to confer immunity against COVID-19 [51].
Wider significance of study findings
The results of the questionnaires indicate a high level of concordance among continents and
specialties regarding priority research themes. They highlight the importance of pursuing
research which has often been overlooked, including addressing the emotional and psycholog-
ical impact of the pandemic on maternal and child health, improving access to antenatal, child
health services and vaccination during the pandemic, particularly in low-resource settings, as
well as investing in long-term follow-up of infants born to women with COVID-19 during the
pandemic.
Addressing these priorities will require diverse research methodologies, including labora-
tory-based analyses, qualitative and quantitative research, and population science. The devel-
opment of generic infrastructure could help foster research collaboration, including the use of
core outcome sets, low cost data repositories, and standardized approaches to the reporting of
research [52]. We have already seen examples of international collaboration in a number of
registries and studies set up to collect data from women who developed COVID-19 during
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pregnancy, including the COVI-PREG, PAN-COVID and periCOVID studies [53–55], and in
consortiums such as The African coaLition for Epidemic Research, Response and Training
(ALERRT), the advisory groups within the WHO Maternal, Newborn, Child and Adolescent
Health and Ageing section and the COVID-19 Clinical Research Coalition, which aim to facili-
tate and coordinate COVID-19 research efforts in LMICs [56–58]. It is hoped the development
of a prioritized research agenda could be an important step in further deepening future inter-
national research collaboration.
Study limitations
There was an over-representation of Central and South American respondents among the
responses to Questionnaire 1. We sought to obtain as many responses from as diverse a group
of respondents as possible, however, it is likely that the questionnaire was more successfully
disseminated via networks in this region compared to other parts of the world. There was also
a preponderance of pediatric infectious diseases societies among the networks through which
Questionnaire 1 was disseminated, which may have skewed responses received towards pediat-
ric infectious diseases specialists. We chose to disseminate the questionnaires through affiliated
memberships of the working group members and via social media as we believed this would
allow a greater inclusion of clinicians and frontline workers as well as researchers in resource-
limited nations. In disseminating the questionnaires using these links, it is possible that our
results may have been subject to sampling bias. To mitigate the effect of these potential biases,
we performed a subgroup analysis to ensure that the views of respondents from all regions and
specialties were equitably reflected among the final list of priority research themes.
There was also a significantly reduced response rate to Questionnaire 2 (21.7% of the origi-
nal pool of respondents), possibly as the dissemination of our second questionnaire coincided
with the second wave of the COVID-19 pandemic in many of the countries where our respon-
dents were based [59–61]. This reduction in engagement may have therefore reflected local
challenges faced by the clinicians and researchers due to an increasing number of COVID-19
cases, although we cannot exclude other causes for this reduced response rate. Given the
degree of attrition, we considered the subgroup preferences from Questionnaire 1 when devel-
oping the final priority research themes to ensure parity among responses and to lessen the
influence of the reduction in response rate on the final research priorities derived from the
questionnaire data. In light of the low response rate to Questionnaire 2, it was also decided
that a modified Delphi approach would be used with only two questionnaire rounds. Given
that there was a high degree of consensus among the answers to Questionnaire 1, we believe
this method remained appropriate for the development of these four priority research themes.
Although space was provided for additional comments from respondents, the use of ques-
tionnaires imposed limitations on the depth of the data we were able to collect. While the ques-
tionnaires were useful for collecting data from a large number of professionals within our
target field, we were limited in our ability to further explore the response we received. Future
work may require a more in-depth exploration of ideas through interviews and focus group
discussions with respondents to further expand the responses given in the questionnaires to
better understand the perceived research priorities within different global regions.
Conclusion
A prioritized list of research uncertainties, developed to specifically highlight the most pressing
clinical and research needs as perceived by healthcare professionals and researchers in both
HICs and LMICs should help funding organizations and researchers to answer pertinent ques-
tions related to pregnancy and childhood during the pandemic. Although there was a great
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degree of consensus among the priorities selected by our questionnaire respondents, it is
important that an approach is undertaken which also sought to identify differences in interna-
tional research needs. The selected list of research uncertainties should serve to focus discus-
sion regarding the allocation of limited resources and priorities should be reviewed on a
regular basis to reflect the evolving availability of evidence.
While global research collaboration is of great importance in furthering our collective
understanding of the effects of COVID-19 on pregnant and breastfeeding women and chil-
dren, it is essential that this research also serves the needs of the population in which the
research is conducted and provides data relevant to their needs. We hope that the findings of
this study will support researchers and policy makers worldwide to better understand the
needs of their region, enabling the prioritization of research that aligns with the priorities of
their communities.
Supporting information
S1 File. Questionnaire 1.
(DOCX)
S2 File. Questionnaire 2.
(DOCX)
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